Exploring the protective effect of metformin against sarcopenia: insights from cohort studies and genetics
Journal of Translational Medicine · 21.03.2025 · 23 (1)
DOI: 10.1186/s12967-025-06357-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Medicine, online erschienen am 21.03.2025. Verfasst von Yanyan Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Metformin, Sarcopenia, Protective Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program, External Collaboration Project.
Abstract (Originalsprache)
Background
The impact of metformin on sarcopenia remains uncertain. This study aimed to investigate whether metformin influences sarcopenia risk and evaluate the effects of potential drug targets on sarcopenia traits.
Methods
We analyzed data from the National Health and Nutrition Examination Survey (NHANES) (n = 3549) to assess the association between metformin use and sarcopenia risk in elderly patients with type 2 diabetes. Mendelian randomization (MR) analysis using genome-wide association studies (GWAS) from UK Biobank (n = 1,366,167) and FinnGen (n = 218,007), with expression quantitative trait loci (eQTL) as instrumental variables, examined the causal effect of metformin-related targets on sarcopenia traits, while molecular docking explored the interaction between metformin and its drug targets.
Results
Metformin use was associated with increased grip strength (OR = 2.46; 95% CI 1.49–2.38) and skeletal muscle mass (OR = 1.24; 95% CI 0.20–2.28), as well as reduced mortality (HR = 0.62; 95% CI 0.54–0.71). MR analysis suggested a possible link between GDF15 gene expression and sarcopenia traits, with no evidence of genetic confounding. Molecular docking indicated stable binding between metformin and GDF15.
Conclusion
This study suggests that metformin may lower sarcopenia risk, particularly in elderly patients with type 2 diabetes, with GDF15 identified as a promising target for sarcopenia treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Women and Children Department of the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Psychology, School of Social and Behavioral Sciences, Nanjing University, Nanjing, Jiangsu, China.
- Department of the Core Facility, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. yujing@njmu.edu.cn.
- Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. 973682801@qq.com.
ORCID-Profile: Yun Liu
Förderung
- National Natural Science Foundation of China
- National Key R&D Program
- External Collaboration Project
- Nanjing Science and Technology Bureau Project
- Social Development Plan of the Provincial Department of Science and Technology
Zitieren
APA
Hu, Y., Lu, S., Xue, C., Hu, Z., Wang, Y., Zhang, W., Wang, D., Wang, J., Ding, G., Yu, J., Hu, Y., & Liu, Y. (2025). Exploring the protective effect of metformin against sarcopenia: insights from cohort studies and genetics. Journal of Translational Medicine, 23(1). https://doi.org/10.1186/s12967-025-06357-x
Vancouver
Hu Y, Lu S, Xue C, Hu Z, Wang Y, Zhang W, et al. Exploring the protective effect of metformin against sarcopenia: insights from cohort studies and genetics. Journal of Translational Medicine. 2025;23(1). doi:10.1186/s12967-025-06357-x
BibTeX
@article{Hu2025,
author = {Hu, Yanyan and Lu, Shan and Xue, Cheng and Hu, Zhaonian and Wang, Yifei and Zhang, Wensong and Wang, Dan and Wang, Jizheng and Ding, Guoxian and Yu, Jing and Hu, Yifang and Liu, Yun},
title = {Exploring the protective effect of metformin against sarcopenia: insights from cohort studies and genetics},
journal = {Journal of Translational Medicine},
year = {2025},
volume = {23},
number = {1},
doi = {10.1186/s12967-025-06357-x}
}
EUVIMED